Why I’m Putting 40% of My Money in Mid-Cap Funds in 2026 (Despite Market Fear) – My Real Portfolio Breakdown

Hey, Harsh this side from Harshonomics.com.
33, Mumbai, married, one daughter, regular 9–5 finance job… and a small blog where I only write about money I’m actually putting on the line.

No theory. No “expert gyaan”. Sirf real paisa, real risk, real decisions.

2025 was brutal. Markets girre, uthe, phir girre.
Aur us time pe maine ek decision liya jo aaj bhi logon ko risky lagta hai:

I’m allocating 40% of every fresh rupee (salary hike, bonus, side income) into mid-cap mutual funds.

Even now… jab Nifty Midcap 100 apne Feb 2025 peak se ~10–12% neeche hai.

Sounds crazy? Maybe.

But yeh article advice nahi hai —
yeh mera open money diary hai.


1. 2025 Reality Check – Mid-Caps Got Hit Hard (Twice)

Let’s not sugarcoat it.

Mid-caps ne 2025 mein investors ko test kiya — mentally bhi aur financially bhi.

Simple language: Agar aap panic ho jaate ho, toh yeh segment aapke liye nahi hai.

Large caps ne manageable fall diya.
Mid-caps ne patience test kiya.
Small caps ne logon ko rula diya.

Hinglish truth:
“Jitna bada fall, utna bada future opportunity — bas survive karna aana chahiye.”


2. The Only 3 Mid-Cap Funds Getting My Money in 2026

Main 20 funds track karta hoon. Invest sirf 3 mein karta hoon.

  • Kotak Emerging Equity Fund
  • PGIM India Midcap Opportunities Fund
  • HDFC Mid-Cap Opportunities Fund

Why these?

  • Crash mein relatively controlled fall
  • Recovery fast (strong fund management)
  • Consistent 5–10 year performance

My current SIP (Jan 2026):

  • ₹60K → Kotak
  • ₹50K → PGIM
  • ₹40K → HDFC

Total: ₹1.5 lakh/month

Yes, aggressive hai. But calculated hai.


3. My Biggest Mistakes (Jo Shayad Tum Avoid Kar Sakte Ho)

  • 2018 crash → panic → loss book kiya
  • 2020 crash → SIP band kar diya (biggest regret)
  • 2022 crash → SIP continue rakha → biggest gains mile

Lesson: Market crash se paisa nahi banta…
crash mein rukne se banta hai.

Real talk:
3 AM pe portfolio check karke anxiety hona normal hai.
Par long-term investor wahi hai jo next day bhi SIP chalu rakhe.


4. Why Mid-Caps Right Now (2026 View)

  • Valuations thode cool hue hain (overheated zone se niche aaye)
  • Growth potential still highest (20%+ earnings growth expected)
  • FIIs abhi bhi under-invested (future inflow potential)
  • Funds ke paas cash ready hai dips buy karne ke liye

Simple logic:
“Growth chahiye → mid-caps ignore nahi kar sakte.”


5. Risks (Jo Main Ignore Nahi Kar Raha)

  • –30% to –40% fall possible hai (anytime)
  • Liquidity issues aa sakte hain extreme situations mein
  • Global recession impact karega

Main mentally prepared hoon:
Agar portfolio 40% girta hai… main SIP badhaunga, band nahi karunga.

Yahi difference hota hai investors aur traders mein.


6. My Exact Strategy (Simple but Powerful)

  • 40% fresh money → mid-caps
  • Lump sum nahi → STP (12 months spread)
  • SIP continue regardless of market

Goal:
2035 tak ₹15–20 crore mid-cap corpus (agar 18–20% CAGR milta hai)

Guaranteed nahi hai.
Possible hai.


7. Who Should Do This (And Who Should Not)

YES if:

  • Age < 45
  • Long-term horizon (7–10 years)
  • Emergency fund ready
  • Market volatility handle kar sakte ho

NO if:

  • Short-term goals hain
  • Daily portfolio check karte ho
  • –20% dekh ke sleep kharab ho jaati hai

Hinglish reality:
“Risk lene ka shauk sabko hota hai… loss dekhne ki capacity sabme nahi hoti.”


Final Confession

Mujhe nahi pata 2026 mein mid-caps 20% denge ya nahi.

Par mujhe ek cheez pata hai:

Har baar jab mid-caps hated the (2016, 2020, 2022, 2025)…
long-term investors ne paisa banaya hai.

History repeat nahi hoti… par rhyme zarur karti hai.

Aur abhi jo chal raha hai… woh familiar lag raha hai.


Final Thought

Market mein do type ke log hote hain:

Jo dip se darte hain
Aur jo dip ka wait karte hain

Decide karo tum kaun ho.

Comment “MIDCAP40” agar tum bhi allocation badha rahe ho —
main apna personal tracker sheet share karunga.

Stay consistent.
Stay boring.
That’s how wealth is built.

Leave a Comment